236 related articles for article (PubMed ID: 31185295)
1. N-Glycan-calnexin interactions in human factor VII secretion and deficiency.
Wang H; Wang L; Li S; Dong N; Wu Q
Int J Biochem Cell Biol; 2019 Aug; 113():67-74. PubMed ID: 31185295
[TBL] [Abstract][Full Text] [Related]
2. N-glycosylation in the protease domain of trypsin-like serine proteases mediates calnexin-assisted protein folding.
Wang H; Li S; Wang J; Chen S; Sun XL; Wu Q
Elife; 2018 Jun; 7():. PubMed ID: 29889025
[TBL] [Abstract][Full Text] [Related]
3. Factor VII deficiency: Unveiling the cellular and molecular mechanisms underlying three model alterations of the enzyme catalytic domain.
Chollet ME; Andersen E; Skarpen E; Myklebust CF; Koehler C; Morth JP; Chuansumrit A; Pinotti M; Bernardi F; Thiede B; Sandset PM; Skretting G
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):660-667. PubMed ID: 29246447
[TBL] [Abstract][Full Text] [Related]
4. Activation of Endoplasmic Reticulum Stress and Unfolded Protein Response in Congenital Factor VII Deficiency.
Andersen E; Chollet ME; Myklebust CF; Pinotti M; Bernardi F; Chuansumrit A; Skarpen E; Sandset PM; Skretting G
Thromb Haemost; 2018 Apr; 118(4):664-675. PubMed ID: 29618153
[TBL] [Abstract][Full Text] [Related]
5. N-glycan in the scavenger receptor cysteine-rich domain of hepsin promotes intracellular trafficking and cell surface expression.
Sun S; Wang L; Zhang S; Zhang C; Chen Y; Wu Q; Dong N
Int J Biol Macromol; 2020 Oct; 161():818-827. PubMed ID: 32553951
[TBL] [Abstract][Full Text] [Related]
6. A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency.
Jiang M; Wang Z; Yu Z; Bai X; Su J; Cao L; Zhang W; Ruan C
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):264-70. PubMed ID: 21372693
[TBL] [Abstract][Full Text] [Related]
7. In vitro expression of mutant factor VII proteins and characterization of their clinical significance.
Mashayekhi A; Shahbazi S; Omrani M; Mahdian R
Mol Med Rep; 2018 Feb; 17(2):2738-2742. PubMed ID: 29207137
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygous mutations (p.Leu13Pro and p.Tyr294*) associated with factor VII deficiency cause impaired secretion through ineffective translocation and extensive intracellular degradation of factor VII.
Suzuki K; Sugawara T; Ishida Y; Suwabe A
Thromb Res; 2013 Feb; 131(2):166-72. PubMed ID: 23141848
[TBL] [Abstract][Full Text] [Related]
9. F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study.
Quintavalle G; Riccardi F; Rivolta GF; Martorana D; Di Perna C; Percesepe A; Tagliaferri A;
Thromb Haemost; 2017 Aug; 117(8):1455-1464. PubMed ID: 28447100
[TBL] [Abstract][Full Text] [Related]
10. Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency.
Branchini A; Ferrarese M; Lombardi S; Mari R; Bernardi F; Pinotti M
J Thromb Haemost; 2016 Oct; 14(10):1994-2000. PubMed ID: 27513915
[TBL] [Abstract][Full Text] [Related]
11. An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes.
Barbon E; Pignani S; Branchini A; Bernardi F; Pinotti M; Bovolenta M
Sci Rep; 2016 Jun; 6():28304. PubMed ID: 27341548
[TBL] [Abstract][Full Text] [Related]
12. Impaired secretion of carboxyl-terminal truncated factor VII due to an F7 nonsense mutation associated with FVII deficiency.
Tanaka R; Nakashima D; Suzuki A; Miyawaki Y; Fujimori Y; Yamada T; Takagi A; Murate T; Yamamoto K; Katsumi A; Matsushita T; Naoe T; Kojima T
Thromb Res; 2010 Mar; 125(3):262-6. PubMed ID: 19822353
[TBL] [Abstract][Full Text] [Related]
13. Spatial position is a key determinant of N-glycan functionality of the scavenger receptor cysteine-rich domain of human hepsin.
Sun S; Hu K; Wang L; Liu M; Zhang Y; Dong N; Wu Q
FEBS J; 2023 Aug; 290(16):3966-3982. PubMed ID: 36802168
[TBL] [Abstract][Full Text] [Related]
14. Truncated N-glycans affect protein folding in the ER of CHO-derived mutant cell lines without preventing calnexin binding.
Ermonval M; Duvet S; Zonneveld D; Cacan R; Buttin G; Braakman I
Glycobiology; 2000 Jan; 10(1):77-87. PubMed ID: 10570226
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII.
Hunault M; Arbini AA; Carew JA; Peyvandi F; Bauer KA
Blood; 1999 Feb; 93(4):1237-44. PubMed ID: 9949166
[TBL] [Abstract][Full Text] [Related]
16. Mutation in the factor VII hepatocyte nuclear factor 4α-binding site contributes to factor VII deficiency.
Zheng XW; Kudaravalli R; Russell TT; DiMichele DM; Gibb C; Russell JE; Margaritis P; Pollak ES
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):624-7. PubMed ID: 21760481
[TBL] [Abstract][Full Text] [Related]
17. Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII.
Bolt G; Kristensen C; Steenstrup TD
Glycobiology; 2005 May; 15(5):541-7. PubMed ID: 15616124
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domain.
D'Andrea G; Bossone A; Lupone MR; Peyvandi F; Maisto G; Perricone F; Grandone E; Margaglione M
Haematologica; 2004 Aug; 89(8):979-84. PubMed ID: 15339682
[TBL] [Abstract][Full Text] [Related]
19. N-glycosylation mediated folding and quality control in serine proteases of the hepsin family.
Bergeron JJM; Thomas DY
FEBS J; 2023 Aug; 290(16):3963-3965. PubMed ID: 37013685
[TBL] [Abstract][Full Text] [Related]
20. Novel factor VII gene mutations in six families with hereditary coagulation factor VII deficiency.
Zhang X; Wang S; Leng S; Feng Q; Zhang Y; Xu S; Zhang L; Zhang X; Fang Y; Peng J; Sheng Z
J Clin Lab Anal; 2021 Sep; 35(9):e23905. PubMed ID: 34342048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
